Development and use of SIV-based Integrase defective lentiviral vector for immunization. 2009

Zuleika Michelini, and Donatella R M Negri, and Silvia Baroncelli, and Massimo Spada, and Pasqualina Leone, and Roberta Bona, and Mary E Klotman, and Andrea Cara
Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy.

Integrase (IN) defective lentiviral vectors have a high safety profile and might prove useful as immunizing agents especially against HIV-1. However, IN defective SIV-based vectors must be developed in order to test their potential in the non-human primate models (NHP) of AIDS. To this aim we tested a novel SIV-based IN defective lentiviral vector for its ability to induce sustained immune responses in mice. BALB/c mice were immunized once intramuscularly with a SIV-based IN defective lentiviral vector expressing the model antigen enhanced green fluorescence protein (eGFP). Immune responses were evaluated 90 days after the injection and compared with those elicited with the IN competent counterpart. The IN defective vector was able to efficiently elicit specific and long-lasting polyfunctional immune responses as evaluated by enzyme-linked immunospot (ELISPOT) assays for interferon-gamma (IFN-gamma) in spleens, bone marrow (BM) and draining lymph nodes, and by intracellular staining (ICS) for IFN-gamma, Interleukin-2 (IL-2) and tumor necrosis factor (TNF-alpha) in both splenocytes and BM cells without integration of the vector into the host genome. This is the first demonstration that an IN defective SIV-based lentiviral vector provides effective immunization, thus paving the way for the construction of IN defective vectors expressing SIV antigen(s) and test their efficacy against a SIV virus challenge in the NHP model of AIDS.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D005260 Female Females
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Zuleika Michelini, and Donatella R M Negri, and Silvia Baroncelli, and Massimo Spada, and Pasqualina Leone, and Roberta Bona, and Mary E Klotman, and Andrea Cara
January 2012, Cell journal,
Zuleika Michelini, and Donatella R M Negri, and Silvia Baroncelli, and Massimo Spada, and Pasqualina Leone, and Roberta Bona, and Mary E Klotman, and Andrea Cara
February 2010, Gene therapy,
Zuleika Michelini, and Donatella R M Negri, and Silvia Baroncelli, and Massimo Spada, and Pasqualina Leone, and Roberta Bona, and Mary E Klotman, and Andrea Cara
February 2018, Human gene therapy methods,
Zuleika Michelini, and Donatella R M Negri, and Silvia Baroncelli, and Massimo Spada, and Pasqualina Leone, and Roberta Bona, and Mary E Klotman, and Andrea Cara
November 2023, Viruses,
Zuleika Michelini, and Donatella R M Negri, and Silvia Baroncelli, and Massimo Spada, and Pasqualina Leone, and Roberta Bona, and Mary E Klotman, and Andrea Cara
April 2004, Human gene therapy,
Zuleika Michelini, and Donatella R M Negri, and Silvia Baroncelli, and Massimo Spada, and Pasqualina Leone, and Roberta Bona, and Mary E Klotman, and Andrea Cara
January 2013, International journal of cancer,
Zuleika Michelini, and Donatella R M Negri, and Silvia Baroncelli, and Massimo Spada, and Pasqualina Leone, and Roberta Bona, and Mary E Klotman, and Andrea Cara
January 2016, Methods in molecular biology (Clifton, N.J.),
Zuleika Michelini, and Donatella R M Negri, and Silvia Baroncelli, and Massimo Spada, and Pasqualina Leone, and Roberta Bona, and Mary E Klotman, and Andrea Cara
January 2022, PeerJ,
Zuleika Michelini, and Donatella R M Negri, and Silvia Baroncelli, and Massimo Spada, and Pasqualina Leone, and Roberta Bona, and Mary E Klotman, and Andrea Cara
June 2020, Molecular therapy. Methods & clinical development,
Zuleika Michelini, and Donatella R M Negri, and Silvia Baroncelli, and Massimo Spada, and Pasqualina Leone, and Roberta Bona, and Mary E Klotman, and Andrea Cara
November 2007, Nature biotechnology,
Copied contents to your clipboard!